TY - JOUR
T1 - Development and Application of Reversible and Irreversible Covalent Probes for Human and Mouse Cathepsin-K Activity Detection, Revealing Nuclear Activity
AU - Dey, Gourab
AU - Sinai-Turyansky, Reut
AU - Yakobovich, Evalyn
AU - Merquiol, Emmanuelle
AU - Loboda, Jure
AU - Sridharan, Nikhila
AU - Houri-Haddad, Yael
AU - Polak, David
AU - Yona, Simon
AU - Turk, Dusan
AU - Wald, Ori
AU - Blum, Galia
N1 - Publisher Copyright:
© 2024 The Author(s). Advanced Science published by Wiley-VCH GmbH.
PY - 2024/10/16
Y1 - 2024/10/16
N2 - Cathepsin-K (CTSK) is an osteoclast-secreted cysteine protease that efficiently cleaves extracellular matrices and promotes bone homeostasis and remodeling, making it an excellent therapeutic target. Detection of CTSK activity in complex biological samples using tailored tools such as activity-based probes (ABPs) will aid tremendously in drug development. Here, potent and selective CTSK probes are designed and created, comparing irreversible and reversible covalent ABPs with improved recognition components and electrophiles. The newly developed CTSK ABPs precisely detect active CTSK in mouse and human cells and tissues, from diseased and healthy states such as inflamed tooth implants, osteoclasts, and lung samples, indicating changes in CTSK's activity in the pathological samples. These probes are used to study how acidic pH stimulates mature CTSK activation, specifically, its transition from pro-form to mature form. Furthermore, this study reveals for the first time, why intact cells and cell lysate exhibit diverse CTSK activity while having equal levels of mature CTSK enzyme. Interestingly, these tools enabled the discovery of active CTSK in human osteoclast nuclei and in the nucleoli. Altogether, these novel probes are excellent research tools and can be applied in vivo to examine CTSK activity and inhibition in diverse diseases without immunogenicity hazards.
AB - Cathepsin-K (CTSK) is an osteoclast-secreted cysteine protease that efficiently cleaves extracellular matrices and promotes bone homeostasis and remodeling, making it an excellent therapeutic target. Detection of CTSK activity in complex biological samples using tailored tools such as activity-based probes (ABPs) will aid tremendously in drug development. Here, potent and selective CTSK probes are designed and created, comparing irreversible and reversible covalent ABPs with improved recognition components and electrophiles. The newly developed CTSK ABPs precisely detect active CTSK in mouse and human cells and tissues, from diseased and healthy states such as inflamed tooth implants, osteoclasts, and lung samples, indicating changes in CTSK's activity in the pathological samples. These probes are used to study how acidic pH stimulates mature CTSK activation, specifically, its transition from pro-form to mature form. Furthermore, this study reveals for the first time, why intact cells and cell lysate exhibit diverse CTSK activity while having equal levels of mature CTSK enzyme. Interestingly, these tools enabled the discovery of active CTSK in human osteoclast nuclei and in the nucleoli. Altogether, these novel probes are excellent research tools and can be applied in vivo to examine CTSK activity and inhibition in diverse diseases without immunogenicity hazards.
KW - activity-based probes
KW - cathepsin K
KW - covalent probes
KW - imaging protease activity
KW - proteases
UR - http://www.scopus.com/inward/record.url?scp=85197938428&partnerID=8YFLogxK
U2 - 10.1002/advs.202401518
DO - 10.1002/advs.202401518
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38970171
AN - SCOPUS:85197938428
SN - 2198-3844
VL - 11
JO - Advanced Science
JF - Advanced Science
IS - 38
M1 - 2401518
ER -